---
figid: PMC7218174__fcell-08-00152-g003
figlink: pmc/articles/PMC7218174/figure/F3/
number: F3
caption: Autophagic compensation in resistance to MET-targeted therapy. CagA protein
  negatively regulates autophagy via the MET-mTOR signaling pathway; MET inhibition
  induces mTOR activation and ULK1 dephosphorylation to increase autophagy; Y1234/1235
  dephosphorylation of MET mediates the metabolic transformation to autophagy; crizotinib
  and oridonin strengthen the positive feedback loop between autophagy and apoptosis
  in the resistance. mTOR, mammalian target of rapamycin; PDHC, pyruvate dehydrogenase
  complex; GLS, glutaminase; ULK1, UNC-51–like kinase.
pmcid: PMC7218174
papertitle: 'Targeting the HGF/MET Axis in Cancer Therapy: Challenges in Resistance
  and Opportunities for Improvement.'
reftext: Xing Huang, et al. Front Cell Dev Biol. 2020;8:152.
pmc_ranked_result_index: '3330'
pathway_score: 0.9238183
filename: fcell-08-00152-g003.jpg
figtitle: Autophagic compensation in resistance to MET-targeted therapy
year: '2020'
organisms: Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7218174__fcell-08-00152-g003.html
  '@type': Dataset
  description: Autophagic compensation in resistance to MET-targeted therapy. CagA
    protein negatively regulates autophagy via the MET-mTOR signaling pathway; MET
    inhibition induces mTOR activation and ULK1 dephosphorylation to increase autophagy;
    Y1234/1235 dephosphorylation of MET mediates the metabolic transformation to autophagy;
    crizotinib and oridonin strengthen the positive feedback loop between autophagy
    and apoptosis in the resistance. mTOR, mammalian target of rapamycin; PDHC, pyruvate
    dehydrogenase complex; GLS, glutaminase; ULK1, UNC-51–like kinase.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - HGF
  - MET
  - S100A8
  - MTOR
  - GLS
  - ULK1
  - Crizotinib
  - oridonin
genes:
- word: HGF
  symbol: HGF
  source: hgnc_symbol
  hgnc_symbol: HGF
  entrez: '3082'
- word: HGF
  symbol: HGF
  source: hgnc_symbol
  hgnc_symbol: HGF
  entrez: '3082'
- word: MET
  symbol: MET
  source: hgnc_symbol
  hgnc_symbol: MET
  entrez: '4233'
- word: МЕТ
  symbol: MET
  source: hgnc_symbol
  hgnc_symbol: MET
  entrez: '4233'
- word: МЕT
  symbol: MET
  source: hgnc_symbol
  hgnc_symbol: MET
  entrez: '4233'
- word: CagA
  symbol: CAGA
  source: hgnc_prev_symbol
  hgnc_symbol: S100A8
  entrez: '6279'
- word: mTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: GLS
  symbol: GLS
  source: hgnc_symbol
  hgnc_symbol: GLS
  entrez: '2744'
- word: ULK1
  symbol: ULK1
  source: hgnc_symbol
  hgnc_symbol: ULK1
  entrez: '8408'
- word: MET
  symbol: MET
  source: hgnc_symbol
  hgnc_symbol: MET
  entrez: '4233'
chemicals:
- word: Crizotinib
  source: MESH
  identifier: C551994
- word: oridonin
  source: MESH
  identifier: C011959
diseases: []
figid_alias: PMC7218174__F3
redirect_from: /figures/PMC7218174__F3
figtype: Figure
---
